Cubist Systematic Strategies, LLC - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 145 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.10 and the average weighting 0.3%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$727,000
+19.0%
61,803
+38.1%
0.01%
-35.0%
Q1 2019$611,000
+259.4%
44,741
+169.6%
0.02%
+150.0%
Q4 2018$170,000
-50.3%
16,597
-23.3%
0.01%
-52.9%
Q2 2018$342,000
-2.6%
21,639
-21.6%
0.02%
-19.0%
Q1 2018$351,000
+26.7%
27,614
+14.1%
0.02%
+40.0%
Q4 2017$277,000
-3.1%
24,209
+3.6%
0.02%
-6.2%
Q3 2017$286,000
+652.6%
23,373
+611.7%
0.02%
+700.0%
Q2 2017$38,000
-54.2%
3,284
-18.2%
0.00%
-71.4%
Q4 2016$83,000
+84.4%
4,013
+190.8%
0.01%
+133.3%
Q3 2016$45,000
+28.6%
1,380
-1.4%
0.00%
+50.0%
Q2 2016$35,000
+52.2%
1,400
+47.1%
0.00%
+100.0%
Q1 2016$23,000
-67.6%
952
-55.6%
0.00%
-75.0%
Q4 2015$71,000
-65.4%
2,142
-65.8%
0.00%
-60.0%
Q3 2015$205,000
-69.0%
6,269
-49.8%
0.01%
-68.8%
Q2 2015$662,000
+321.7%
12,495
+130.4%
0.03%
+300.0%
Q1 2015$157,000
+946.7%
5,424
+971.9%
0.01%
+700.0%
Q4 2014$15,0005060.00%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 2,942,130$37,365,0008.14%
Foresite Capital Management II, LLC 1,686,220$21,415,0007.12%
Foresite Capital Management IV, LLC 830,919$10,553,0004.38%
SENZAR ASSET MANAGEMENT, LLC 822,890$10,451,0003.30%
Redmile Group, LLC 6,505,766$82,623,0003.19%
DAFNA Capital Management LLC 396,013$5,029,0002.45%
SECTORAL ASSET MANAGEMENT INC 863,600$10,968,0001.20%
Palo Alto Investors LP 1,849,832$23,493,0001.00%
Bellevue Group AG 700,464$8,896,0000.88%
Rock Springs Capital Management LP 1,529,800$19,428,0000.83%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders